CV Therapeutics, Quintiles sales and marketing update

The companies amended a 1999 deal for QTRN's Innovex subsidiary (Parsippany, N.J.) to provide a sales force and fund marketing activities in the U.S. for CVTX's Ranexa ranolazine, which is under FDA ...